4-aminopyridine has been researched along with Encephalopathy, Toxic in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a 45-year old female multiple sclerosis patient, who accidentally was overdosed with 4-aminopyridine which resulted in dystonic, choreathetoid type abnormal movements in the four limbs, motoric distress, confusion and opisthotonus." | 7.75 | An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy? ( Couvreur, F; De Cauwer, H; De Wolf, P; Mortelmans, L, 2009) |
| " Anticonvulsant effects were evaluated against seizures induced by 14 mg kg(-1) of 4-aminopyridine (4-AP) and by 110 mg kg(-1) of pentylenetetrazole (PTZ), and neurotoxicity by the rotarod test." | 7.72 | Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial? ( Amat, G; Armijo, JA; Cuadrado, A, 2003) |
| "We report the case of a 45-year old female multiple sclerosis patient, who accidentally was overdosed with 4-aminopyridine which resulted in dystonic, choreathetoid type abnormal movements in the four limbs, motoric distress, confusion and opisthotonus." | 3.75 | An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy? ( Couvreur, F; De Cauwer, H; De Wolf, P; Mortelmans, L, 2009) |
| " Anticonvulsant effects were evaluated against seizures induced by 14 mg kg(-1) of 4-aminopyridine (4-AP) and by 110 mg kg(-1) of pentylenetetrazole (PTZ), and neurotoxicity by the rotarod test." | 3.72 | Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial? ( Amat, G; Armijo, JA; Cuadrado, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, P | 1 |
| Kang, SY | 1 |
| Yu, KN | 1 |
| Kothapalli, C | 1 |
| Lee, MY | 1 |
| Harris, TL | 1 |
| Lowery, CA | 1 |
| Hixon, MS | 1 |
| Janda, KD | 1 |
| Chang, CY | 1 |
| Lin, TY | 1 |
| Lu, CW | 1 |
| Huang, SK | 1 |
| Wang, YC | 1 |
| Chou, SS | 1 |
| Wang, SJ | 1 |
| De Cauwer, H | 1 |
| De Wolf, P | 1 |
| Couvreur, F | 1 |
| Mortelmans, L | 1 |
| Cuadrado, A | 1 |
| Amat, G | 1 |
| Armijo, JA | 1 |
5 other studies available for 4-aminopyridine and Encephalopathy, Toxic
| Article | Year |
|---|---|
High-content imaging of 3D-cultured neural stem cells on a 384-pillar plate for the assessment of cytotoxicity.
Topics: 4-Aminopyridine; Apoptosis; Cell Culture Techniques; Cell Line; Cell Survival; Digoxin; DNA Damage; | 2020 |
A platform stratifying a sequestering agent and a pharmacological antagonist as a means to negate botulinum neurotoxicity.
Topics: 4-Aminopyridine; Amifampridine; Animals; Botulinum Antitoxin; Botulinum Toxins; Drug Therapy, Combin | 2014 |
Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats.
Topics: 4-Aminopyridine; Animals; Calcium; Disease Models, Animal; Egtazic Acid; Enzyme Inhibitors; Excitato | 2015 |
An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy?
Topics: 4-Aminopyridine; Epilepsy, Tonic-Clonic; Female; Humans; Middle Aged; Multiple Sclerosis; Neurotoxic | 2009 |
Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial?
Topics: 4-Aminopyridine; Analysis of Variance; Animals; Brain; Chromatography, Liquid; Disease Models, Anima | 2003 |